| 摘要 |
<p>Use of compound Leonurine or a pharmaceutically acceptable salt thereof or a solvate thereof in the manufacture of a medicament having the effect of reducing the release of LDH; use of compound Leonurine or a pharmaceutically acceptable salt thereof or a solvate thereof in the manufacture of a medicament for preventing and/or treating acute myocardial infarction or heart failure; and a pharmaceutical composition for preventing and/or treating acute myocardial infarction or heart failure are disclosed.</p> |
